• 1. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
• 2. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 3. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 4. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 5. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161

Professional Introduction to 2-Fluoro-4-nitrobenzoic acid t-butyl ester (CAS No: 157665-46-8)

2-Fluoro-4-nitrobenzoic acid t-butyl ester, with the chemical identifier CAS No. 157665-46-8, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound serves as a crucial intermediate in the synthesis of various bioactive molecules, particularly those targeting neurological and inflammatory disorders. Its unique structural properties, characterized by the presence of both a fluoro substituent and a nitro group on a benzoic acid backbone, make it an intriguing candidate for further exploration in drug development.

The significance of this compound lies in its versatility as a building block for more complex pharmacophores. The fluoro group, known for its ability to modulate metabolic stability and binding affinity, enhances the compound's potential as a drug candidate. In contrast, the nitro group introduces electrophilicity, which can be exploited in further chemical transformations to achieve desired biological activities. The tert-butyl ester moiety not only provides stability during synthetic processes but also influences solubility and metabolic pathways, making it a valuable component in medicinal chemistry.

Recent advancements in computational chemistry have highlighted the role of 2-Fluoro-4-nitrobenzoic acid t-butyl ester in virtual screening campaigns. Studies have demonstrated its potential as a scaffold for developing novel inhibitors targeting enzymes involved in pain signaling and neuroinflammation. For instance, researchers have utilized molecular docking simulations to identify derivatives of this compound that exhibit high binding affinity to cyclooxygenase-2 (COX-2), a key enzyme in the prostaglandin synthesis pathway associated with inflammation and pain.

In parallel, experimental investigations have explored the pharmacological properties of this compound. Initial in vitro studies have shown that certain derivatives exhibit anti-inflammatory effects by modulating cytokine production and inhibiting NF-κB signaling pathways. These findings are particularly relevant given the increasing prevalence of chronic inflammatory diseases worldwide. Moreover, the incorporation of fluorine into drug molecules has been linked to improved pharmacokinetic profiles, including enhanced bioavailability and prolonged half-life.

The synthetic methodologies for preparing 2-Fluoro-4-nitrobenzoic acid t-butyl ester have also seen significant refinements. Modern synthetic routes leverage catalytic processes and green chemistry principles to improve yield and reduce waste. For example, transition metal-catalyzed cross-coupling reactions have been employed to introduce fluorine atoms efficiently into the benzoic acid framework. Additionally, solvent-free reactions and microwave-assisted synthesis have been explored to minimize environmental impact while maintaining high reaction efficiency.

The role of this compound in medicinal chemistry extends beyond its use as an intermediate. It has been employed in the development of probes for biochemical assays, allowing researchers to investigate enzyme mechanisms and identify novel therapeutic targets. The nitro group's reactivity also facilitates functionalization through reduction or diazotization reactions, enabling the creation of diverse analogues with tailored biological activities.

The growing interest in fluorinated compounds stems from their unique electronic properties and their impact on molecular interactions. Fluorine atoms can significantly alter hydrophobicity, lipophilicity, and metabolic stability, making them indispensable in modern drug design. The nitro group further contributes to these properties by introducing polarizability and electron-withdrawing effects, which can fine-tune binding interactions with biological targets.

In conclusion, 2-Fluoro-4-nitrobenzoic acid t-butyl ester (CAS No: 157665-46-8) represents a promising compound in pharmaceutical research due to its structural versatility and functional properties. Its applications span from intermediate synthesis to drug development, with particular relevance in addressing neurological and inflammatory disorders. As research continues to uncover new therapeutic possibilities, this compound is poised to play an integral role in shaping the future of medicinal chemistry.

• 526218-22-4(2-fluoro-5-nitro-benzoic acid tert-butyl ester)
• 363-32-6(Ethyl 2-fluoro-4-nitrobenzoate)
• 392-09-6(Methyl 2-fluoro-4-nitrobenzoate)
• 367-79-3(Ethyl 2-fluoro-5-nitrobenzoate)
• 2965-22-2(Methyl 2-fluoro-5-nitrobenzoate)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)